Analysis and Perspectives

Oct 03, 2022

Presently, the FDA-approved drugs available in the market for CTCL treatment include Istodax, Valchlor, Uvadex, Targretin, and others.

Sep 28, 2022

Assistive technologies, such as hearing aids, cochlear implants, and other devices, are playing a key role in Hearing Loss management.

Sep 26, 2022

With a strong idiopathic pulmonary fibrosis treatment market presence in place, Boehringer is developing another drug, BI 1015550.

Sep 12, 2022

Several severe asthma therapies are currently under investigation by leading pharma goliaths for treating patients with severe asthma.

Sep 09, 2022

Pancreatic Cancer treatment outlook is evolving at an immense pace. Globally, several key companies are developing novel therapies

Sep 09, 2022

Following the changing alopecia areata treatment scenarios, DelveInsight aims to draw attention to newly approved therapy for alopecia areata.

Sep 07, 2022

With the approval from FDA, many Digital Therapeutics products are launched in the market over the years, providing health benefits to patients

Sep 05, 2022

To cater to the unmet need in the WHIM syndrome treatment market, leading companies across the globe are working in the therapeutics space

Sep 02, 2022

First drug approved in primary sclerosing cholangitis treatment market by companies will have a competitive advantage in therapeutic domain.

Aug 31, 2022

Digital Twin in Healthcare is disrupting the industry trends with its application and benefits. Companies are working on innovative solutions